Role of Novel Polyherbal Formulations in Secondary Complications like Peripheral Neuropathy in Streptozotocin-Induced Diabetic Wistar Rats
1, 1★★ Corresponding author
- 1Vedica College of B. Pharmacy, RKDF University, Gandhinagar, Bhopal, Madhya Pradesh, INDIA.
CORRESPONDENCE
Mohan Lal Kori
Vedica College of B. Pharmacy, RKDF University, Gandhinagar, Bhopal, Madhya Pradesh, INDIA.
Received: 11-05-2022; Revised: 06-06-2022; Accepted: 27-07-2022.
Volume 13, Issue 1 · pp. 139-148 · 2022 · DOI: 10.5530/223097131485
ABSTRACT
Background: Diabetes becomes a chronic disease when glucose constantly remains high and uncontrolled. As time goes off, it may gradually develop acute or chronic associated complications. Diabetic neuropathy is one of the chronic microvascular complications, reported to affect 25% of the diabetic patient and makes patient’s life disabled and life-threatening. Hence, the present research study was designed to evaluate a novel antidiabetic polyherbal formulation, for its activity against diabetic neuropathy induced in an animal model by using streptozotocin.Materials and Methods: Novel polyherbal formulations were developed and were evaluated against streptozotocin-nicotinamide-induced diabetic neuropathy using 8–10 weeks old Wistar albino rats. Animals with diabetic neuropathy were subjected to standard neuro-protective evaluation parameters, including mechanical, chemical, and thermal tests.Results: Streptozotocin-induced hyperglycemia developed chronic neuropathic symptoms in the experimental rats between 25 - 28 days. Treatments with all four tests PHF for 8 weeks significantly improved the thermal sensation, hyperalgesia, muscle grip strength, and locomotor activity.Conclusion: By detailed research study it was revealed that out of the four polyherbal formulations studied. PHF 4 having the plant ratio of: H. sabdariffa (100): A. marmelos (50): F. religiosa (75): A. squamosa (25), the result was significantly (p < 0.001) better than PHF 2, 8 and 10 (p < 0.01) in reversing the symptoms of diabetic neuropathy. Thus, it was concluded that PHF 4 is excellent in treating diabetic neuropathy as well have excellent potential to prevent further progression and thus can be used against diabetic peripheral neuropathy.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Gupta, V., & Kori, M. L. (2022). Role of Novel Polyherbal Formulations in Secondary Complications like Peripheral Neuropathy in Streptozotocin-Induced Diabetic Wistar Rats. International Journal of Pharmaceutical Investigation, 13(1), 139-148. https://doi.org/10.5530/223097131485
Copyright and licence
© 2022 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0